Table 2. Differences among leishmaniasis and co-infected leishmaniasis-HIV cases based hospitalizations, with leishmaniasis as first diagnosis. Spain 1997–2011.
Variables | Leishmania as first diagnosis (n = 3442) | ||||||
---|---|---|---|---|---|---|---|
VIH positive | VIH negative | Unadjusted OR | Adjusted OR | ||||
N | % | N | % | ||||
No. of subjects | 1255 | 36.46 | 2187 | 63,54 | |||
Sex | Female | 171 | 13.6 | 726 | 33.2 | 1 | 1 |
Male | 1084 | 86.4 | 1461 | 66.8 | 2.22 (1.93–2.56)** | 1.50 (1.17–1.91) * | |
Age group | 0–15 | 0 | 0.0 | 820 | 37.5 | 1 | 1 |
16–64 | 1248 | 99.4 | 992 | 45.4 | 1032 (144.9–7344) ** | 990 (138.76–7065.63) ** | |
>65 | 7 | 0.6 | 375 | 17.1 | 0.07 (0.01–0.53) ** | 0.02 (0.01–0.03) ** | |
Leishmaniasis | Cutaneous | 13 | 1.0 | 105 | 4.8 | 1 | 1 |
Visceral | 1107 | 88.2 | 1737 | 79.4 | 5.15 (2.88–9.20) ** | 6.07 (3.27–11.28) ** | |
Non-defined | 135 | 10.8 | 345 | 15.8 | 0.32 (0.18–0.60) ** | 0.06 (0.06–0.77) ** | |
Type of discharge | No Exitus | 1252 | 94.3 | 2042 | 96.5 | 1 | 1 |
Exitus | 48 | 3.6 | 59 | 2.8 | 1.33 (0.90–1.96) | – | |
Unknown | 27 | 2.0 | 14 | 0.7 | 3.14 (1.64–6.02) ** | 4.18 (1.50–11.66) * | |
Re-hospitalization | No | 887 | 70.7 | 1732 | 79.2 | 1 | 1 |
Yes | 368 | 29.3 | 455 | 20.8 | 1.56 (1.35–1.85) ** | 1.69 (1.35–2.12) ** | |
Surgery | No | 1185 | 94.4 | 1994 | 91.2 | 1 | 1 |
Yes | 70 | 5.6 | 193 | 8.8 | 0.61 (0.46–0.81) ** | 1.75 (1.24–2.47) ** | |
Days of stay | ≤15 days | 852 | 67.9 | 1486 | 67.9 | 1 | – |
> 16 days | 403 | 32.1 | 701 | 32.1 | 1 (0.86–1.16) | – | |
Solid neoplasm | No | 1230 | 98.0 | 2165 | 99.0 | 1 | 1 |
Yes | 25 | 2.0 | 22 | 1.0 | 2 (1.12–3.56)* | 4.45 (1.65–12.04) * | |
Lymph- hematopoietic neoplasms | No | 1246 | 99.3 | 2132 | 97.5 | 1 | 1 |
Yes | 9 | 0.7 | 55 | 2.5 | 0.28 (0.14–0.57) ** | 0.25 (0.11–0.57) * | |
Other immunodeficiencies | No | 1255 | 99.9 | 2149 | 98.3 | 1 | 1 |
Yes | 1 | 1.0 | 37 | 1.7 | 0.05 (0.01–0.34) ** | 0.04 (0.01–0.32) * | |
Transplant | No | 1255 | 100.0 | 2098 | 95.9 | 1 | 1 |
Yes | 0 | 0.0 | 89 | 4.1 | 0.01 (0.01–0.14) ** | 0.01 (0.00–0.07) ** | |
Transplant failure | No | 1245 | 99.2 | 2160 | 98.8 | 1 | – |
Yes | 10 | 0.8 | 27 | 1.2 | 0.64 (0.31–1.33) | – | |
Aplastic Anemia | No | 1078 | 85.9 | 1856 | 84.9 | 1 | – |
Yes | 177 | 14.1 | 331 | 15.1 | 0.92 (0.76–1.12) | – | |
Diabetes Mellitus | No | 1244 | 99 | 2009 | 91.9 | 1 | 1 |
Yes | 12 | 1 | 177 | 8.1 | 0.11 (0.06–0.20) ** | 0.10 (0.05–0.18) ** | |
Hepatitis | No | 1112 | 88.6 | 2153 | 98.4 | 1 | 1 |
Yes | 143 | 11.4 | 34 | 1.6 | 8.14 (5.56–11.92) ** | 3.95 (2.52–6.20) ** | |
Long term use of steroids | No | 1255 | 100.0 | 2171 | 99.3 | 1 | 1 |
Yes | 0 | 0.0 | 16 | 0.7 | 0.11 (0.01–0.81) * | 0.69 (0.05–9.65) | |
Long-term drug use | No | 1219 | 97.1 | 2168 | 99.1 | 1 | 1 |
Yes | 36 | 2.9 | 19 | 0.9 | 3.37 (1.92–5.19) ** | 2.97 (1.40–6.33) * | |
Alcoholism | No | 1183 | 94.3 | 2143 | 98.0 | 1 | 1 |
Yes | 72 | 5.7 | 44 | 2.0 | 2.96 (2.02–4.34) ** | 1.76 (1.12–2.78) * | |
Institutionalized | No | 1147 | 91.4 | 2169 | 99.2 | 1 | 1 |
Yes | 108 | 8.6 | 18 | 0.8 | 11.35 (6.85–18.78) ** | 3.96 (2.27–6.91) ** | |
Lack of resources | No | 1245 | 99.2 | 2183 | 99.8 | 1 | 1 |
Yes | 10 | 0.8 | 4 | 0.2 | 4.38 (1.37–14.03) * | 4.53 (0.84–24.46) |
* p<0.05;
** p<0.001.